This announcement is a separate document:
わかもと製薬株式会社：緑内障・高眼圧症治療剤「ＷＰ-1303」の開発中止に関するお知らせ
Wakamoto Pharmaceutical Co Ltd: Notice on the suspension of the development of the therapeutic agent "WP-1303" for glaucoma hypertension
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.